The Chicago Entrepreneur

Eli Lilly misses on earnings but raises full-year guidance

The company reported adjusted earnings of $1.62, which missed analyst expectations of $1.73 for the quarter.

Previous post Southwest posts wider-than-expected loss as toll of holiday crisis stretches into 2023
Next post Merck revenue falls after dramatic drop in sales of Covid antiviral treatment